Axon Enterprise, Inc $AXON Stock Position Decreased by Milestone Asset Management LLC

by · The Markets Daily

Milestone Asset Management LLC decreased its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 94.1% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 281 shares of the biotechnology company’s stock after selling 4,493 shares during the quarter. Milestone Asset Management LLC’s holdings in Axon Enterprise were worth $202,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in AXON. Brighton Jones LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth $480,000. Axiom Investors LLC DE bought a new position in Axon Enterprise during the first quarter valued at about $93,088,000. CreativeOne Wealth LLC lifted its position in shares of Axon Enterprise by 9.9% in the first quarter. CreativeOne Wealth LLC now owns 4,748 shares of the biotechnology company’s stock worth $2,497,000 after buying an additional 429 shares during the last quarter. Ieq Capital LLC boosted its stake in shares of Axon Enterprise by 7.0% during the 1st quarter. Ieq Capital LLC now owns 3,368 shares of the biotechnology company’s stock worth $1,771,000 after acquiring an additional 219 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. AG increased its holdings in shares of Axon Enterprise by 28.1% during the 1st quarter. B. Metzler seel. Sohn & Co. AG now owns 7,842 shares of the biotechnology company’s stock valued at $4,124,000 after acquiring an additional 1,719 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Cowen restated a “buy” rating on shares of Axon Enterprise in a report on Wednesday, November 5th. Needham & Company LLC restated a “buy” rating and issued a $870.00 price objective on shares of Axon Enterprise in a research note on Wednesday, September 24th. Wall Street Zen lowered shares of Axon Enterprise from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. JMP Securities reaffirmed a “market outperform” rating and issued a $825.00 price target on shares of Axon Enterprise in a research report on Monday, September 29th. Finally, The Goldman Sachs Group dropped their target price on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating on the stock in a research report on Wednesday, November 5th. Fourteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $802.71.

Read Our Latest Stock Analysis on AXON

Insider Activity at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $552.60, for a total transaction of $11,052,000.00. Following the sale, the president directly owned 249,502 shares of the company’s stock, valued at approximately $137,874,805.20. The trade was a 7.42% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Brittany Bagley sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the sale, the chief financial officer owned 93,592 shares in the company, valued at approximately $66,813,456.96. This represents a 5.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 65,540 shares of company stock worth $39,201,438 in the last ninety days. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Price Performance

Shares of AXON stock opened at $591.15 on Friday. Axon Enterprise, Inc has a 12 month low of $469.24 and a 12 month high of $885.91. The company has a market capitalization of $46.65 billion, a P/E ratio of 187.07, a P/E/G ratio of 135.77 and a beta of 1.40. The stock has a 50 day moving average of $601.45 and a two-hundred day moving average of $702.84. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). Axon Enterprise had a net margin of 10.05% and a return on equity of 4.29%. The firm had revenue of $710.64 million during the quarter, compared to analyst estimates of $704.83 million. During the same quarter in the previous year, the company posted $1.45 earnings per share. The business’s revenue for the quarter was up 30.6% compared to the same quarter last year. As a group, equities analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Featured Articles

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).